Hari, Y., Harashima, N., Tajima, Y., & Harada, M. (2015). Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL. Oncotarget.
Παραπομπή Chicago StyleHari, Yoko, Nanae Harashima, Yoshitsugu Tajima, και Mamoru Harada. "Bcl-xL Inhibition By Molecular-targeting Drugs Sensitizes Human Pancreatic Cancer Cells to TRAIL." Oncotarget 2015.
Παραπομπή MLAHari, Yoko, Nanae Harashima, Yoshitsugu Tajima, και Mamoru Harada. "Bcl-xL Inhibition By Molecular-targeting Drugs Sensitizes Human Pancreatic Cancer Cells to TRAIL." Oncotarget 2015.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.